玉米须总黄酮对大鼠尿酸性肾病的改善作用及其机制

doi:10.13481/j.1671-587X.20250409

Abstract

Abstract:

Objective To discuss the ameliorative effect of total flavonoids from corn silk （TFCS） on kidney injury in the rats with urate nephropathy， and to clarify the possible mechanism. Methods Sixty male Wistar rats were randomly divided into control group， model group， positive control group ［benzbromarone（BZM） group， 5 mg·kg^-1·d^-1］， low dose of TFCS group （20 mg·kg^-1·d^-1）， medium dose of TFCS group （40 mg·kg^-1·d^-1）， and high dose of TFCS group （80 mg·kg^-1·d^-1）， and there were 10 rats in each group. Except for control group， the rats in the other groups were administered potassium oxonate （350 mg·kg^-1） and adenine （70 mg·kg^-1） by gavage for 4 weeks to establish the hyperuricemic nephropthy models. The rats in different doses of TFCS groups were treated with TFCS for 2 weeks. Speckle blood flow imager was used to detect the renal blood perfusion of the rats in various groups and the kidney coefficients of the rats in various groups were caculated； HE staining and Masson staining were used to observe the pathomorphology and fibrosis degrees of kidney tissue of the rats in various groups and enzyme-linked immunosorbent assay（ELISA） method was used to detect the levels of uric acid （UA）， creatinine （Cr）， blood urea nitrogen （BUN）， interleukin-6 （IL-6）， and tumor necrosis factor-α （TNF-α） in the serum and levels of β2-microglobulin （β₂-MG） and microalbumin （ALB） in the urine of the rats in various groups； Western blotting method was used to detect the expression levels of urate transporter 1 （URAT1）， glucose transporter 9 （GLUT9）， and ATP-binding cassette transporter G2 （ABCG2） proteins in kidney tissue of the rats in various groups. Results Compared with control group， the renal blood perfusion volume of the rats in model group was significantly decreased （P<0.01）. Compared with model group， the renal blood perfusion volumes of the rats in BZM group and low， medium， and high doses of TFCS groups were significantly increased （P<0.05 or P<0.01）. Compared with control group， the kidney weight of the rats in model group was increased， with visible white granular spots on the surface， absence of blood color， and kidney volume was increased. Compared with model group， the kidney volumes of the rats in BZM group and medium and high doses of TFCS groups were decreased， with color tending toward that in control group， and the white granular spots on the surface were significantly reduced. Compared with model group， the kidney coefficients of the rats in BZM group and medium and high doses of TFCS groups were decreased （P<0.01）. The HE staining results showed there were no abnormalities in kidney tissue structure in control group， while there were a small amount of brown-yellow urate crystal deposition and interstitial connective tissue hyperplasia in model group； compared with model group， the kidney tissue damage and inflammatory infiltration were alleviated to varying degrees in BZM group and different doses of TFCS groups. The Masson staining results revealed no obvious collagen fiber deposition in control group， whereas significant blue collagen fiber deposition in kidney tissue of the rats was found in model group， and the collagen volume fraction （CVF） was increased compared with control group （P<0.01）； compared with model group， the CVFs of the rats in BZM group and different doses of TFCS groups were decreased （P<0.01）. The ELISA results showed that compared with control group， the levels of UA， Cr， BUN， IL-6， and TNF-α in serum of the rats in model group were increased （P<0.01）； compared with model group， the levels of UA， Cr， BUN， IL-6， and TNF-α in serum of the rats in BZM group and medium and high doses of TFCS groups were decreased （P<0.01）. Compared with control group， the levels of β₂-MG and ALB in urinary in model group were increased （P<0.01）； compared with model group， the levels of β₂-MG and ALB in urinary of the rats in different doses of TFCS groups were decreased （P<0.05 or P<0.01）. The Western blotting results showed that compared with control group， the expression levels of URAT1 and GLUT9 proteins in kidney tissue of the rats in BZM group and model group were increased （P<0.01）， while the expression level of ABCG2 protein was decreased （P<0.01）. Compared with model group， the expression levels of URAT1 and GLUT9 proteins in kidney tissue of the rats in different doses of TFCS groups were decreased （P<0.05 or P<0.01）， and the expression level of ABCG2 protein was increased （P<0.01）. Conclusion TFCS can significantly alleviate the kidney injury in the rats with urate nephropathy model， and its mechanism may be related to the downregulation of expression of URAT1 and GLUT9 proteins and upregulation of ABCG2 protein expression in kidney tissue.

Key words: Extract of total flavonoids from corn silk, Urate nephropathy, Blood perfusion, Uric acid transporter, Kidney injury

CLC Number:

Jing LU,Mengmeng LIU,Yuewei HAN,Xiaowei HUANG,Yuchen WANG,He LIN,Tianzhu ZHANG,Zhe LIN,Guangfu LYU. Ameliorative effect of total flavonoids from corn silk on urate nephropathy in rats and its mechanism[J].Journal of Jilin University(Medicine Edition), 2025, 51(4): 929-938.

Figures/Tables 11

Tab.1

Fig. 1

Fig. 2

Tab.2

Fig. 3

Fig. 4

Tab.3

Tab.4

Tab.5

Fig. 5

Tab.6

References 31

[1]	DU L， ZONG Y， LI H R， et al. Hyperuricemia and its related diseases： mechanisms and advances in therapy［J］. Signal Transduct Target Ther， 2024， 9（1）： 212.
[2]	KUWABARA M， KODAMA T， AE R， et al. Update in uric acid， hypertension， and cardiovascular diseases［J］. Hypertens Res， 2023， 46（7）： 1714-1726.
[3]	RHO Y H， ZHU Y Y， CHOI H K. The epidemiology of uric acid and fructose［J］. Semin Nephrol， 2011， 31（5）： 410-419.
[4]	TORRALBA K D， DE JESUS E， RACHABATTULA S. The interplay between diet， urate transporters and the risk for gout and hyperuricemia： current and future directions［J］. Int J Rheum Dis， 2012， 15（6）： 499-506.
[5]	ZHENG Y， CHEN Z R， YANG J Y， et al. The role of hyperuricemia in cardiac diseases： evidence， controversies， and therapeutic strategies［J］. Biomolecules， 2024， 14（7）： 753.
[6]	范丽妃，郭玉琴，林敏，等.基于自噬途径探讨补阳还五汤合抵挡汤改善尿酸性肾病大鼠肾脏损伤的作用机制［J］.中华中医药杂志，2024，39（8）：3989-3995.
[7]	李东东，刘伟伟，周子正，等. 降尿酸方对尿酸性肾病大鼠肾脏细胞凋亡的影响［J］. 中国中医药信息杂志， 2022， 29（6）： 49-54.
[8]	夏新泽，赖文辉，黄帅，等. 2型糖尿病合并终末期肾病患者同期胰肾联合移植术后危险因素： UNOS数据库50230例分析［J］. 解放军医学杂志， 2024， 49（4）： 371-379.
[9]	王倩茹，侯久文，梅其炳，等.人类肾脏疾病动物模型研究进展［J］.神经药理学报，2023，13（4）：29-35.
[10]	ZHENG Z H， HARMAN J L， CORESH J， et al. The dietary fructose： vitamin C intake ratio is associated with hyperuricemia in African-American adults［J］. J Nutr， 2018， 148（3）： 419-426.
[11]	JOHNSON R J， NAKAGAWA T， JALAL D， et al. Uric acid and chronic kidney disease： which is chasing which？［J］. Nephrol Dial Transplant， 2013， 28（9）： 2221-2228.
[12]	CALIXTO FERNANDES M H， SCHRICKER T， MAGDER S， et al. Perioperative fluid management in kidney transplantation： a black box［J］. Crit Care， 2018， 22（1）： 14.
[13]	ALHUMMIANY B， SHARMA K， BUCKLEY D L， et al. Physiological confounders of renal blood flow measurement［J］. MAGMA， 2024， 37（4）： 565-582.
[14]	BEIERWALTES W H， HARRISON-BERNARD L M， SULLIVAN J C， et al. Assessment of renal function； clearance， the renal microcirculation， renal blood flow， and metabolic balance［J］. Compr Physiol， 2013， 3（1）： 165-200.
[15]	KO J， KANG H J， KIM D A， et al. Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding［J］. FASEB J， 2019， 33（12）： 13334-13345.
[16]	PAN J， SHI M， MA L， et al. Mechanistic insights of soluble uric acid-related kidney disease［J］. Curr Med Chem， 2020， 27（30）： 5056-5066.
[17]	UEMURA T， NISHIMOTO M， ERIGUCHI M， et al. Utility of serum β2-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathy［J］. Diabetes Obes Metab， 2024， 26（2）： 583-591.
[18]	WANG Y C， HUANG M， DU X， et al. Renal tubular cell necroptosis： a novel mechanism of kidney damage in trichloroethylene hypersensitivity syndrome mice［J］. J Immunotoxicol， 2021， 18（1）： 173-182.
[19]	阮颖新，贾俊亚，武占飞，等. NLRP3炎症小体在大鼠单侧输尿管梗阻引起肾间质纤维化中的作用及其机制［J］. 吉林大学学报（医学版）， 2024， 50（3）： 587-595.
[20]	WANG M， LIN X， YANG X M， et al. Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease［J］. Ren Fail， 2022， 44（1）： 615-624.
[21]	BRAGA T T， FORESTO-NETO O， CAMARA N O S. The role of uric acid in inflammasome-mediated kidney injury［J］. Curr Opin Nephrol Hypertens， 2020， 29（4）： 423-431.
[22]	KONO H， CHEN C J， ONTIVEROS F， et al. Uric acid promotes an acute inflammatory response to sterile cell death in mice［J］. J Clin Invest， 2010， 120（6）： 1939-1949.
[23]	闫书博，冯聪慧，张原宾，等. 玉米须功能性成分及药理价值研究进展［J］. 食品工程， 2023（3）： 7-9.
[24]	LI H L， SHI L， CHEN X L， et al. Association between dietary intake of flavonoids and hyperuricemia： a cross-sectional study［J］. BMC Public Health， 2023， 23（1）： 1227.
[25]	YE C， HUANG X J， WANG R Y， et al. Dietary inflammatory index and the risk of hyperuricemia： a cross-sectional study in Chinese adult residents［J］. Nutrients， 2021， 13（12）： 4504.
[26]	LODHI S， VADNERE G P， PATIL K D， et al. Protective effects of luteolin on injury induced inflammation through reduction of tissue uric acid and pro-inflammatory cytokines in rats［J］. J Tradit Complement Med， 2019， 10（1）： 60-69.
[27]	YANG Y， ZHANG J L， ZHOU Q. Targets and mechanisms of dietary anthocyanins to combat hyperglycemia and hyperuricemia： a comprehensive review［J］. Crit Rev Food Sci Nutr， 2022， 62（4）： 1119-1143.
[28]	OTANI N， OUCHI M， MISAWA K， et al. Hypouricemia and urate transporters［J］. Biomedicines， 2022， 10（3）： 652.
[29]	HOSOYAMADA M， TSURUMI Y， HIRANO H， et al. Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury［J］. Nucleosides Nucleotides Nucleic Acids， 2016， 35（10-12）： 543-549.
[30]	TOYODA Y， CHO S K， TASIC V， et al. Identification of a dysfunctional exon-skipping splice variant in GLUT9/SLC2A9 causal for renal hypouricemia type 2［J］. Front Genet， 2023， 13： 1048330.
[31]	ECKENSTALER R， BENNDORF R A. The role of ABCG2 in the pathogenesis of primary hyperuricemia and gout-an update［J］. Int J Mol Sci， 2021， 22（13）： 6678.

Group	Perfusion volume（PU）	Average area under curve（PU·mm²）
Control	308.81±16.47	8 971.45±338.27
Model	243.09±17.67^*	6 689.36±523.58^*
BZM	275.23±16.05^△△	7 547.09±642.23^△△
TFCS
Low dose	272.63±10.71^△	6 816.57±278.40
Medium dose	276.22±16.47^△△	7 268.67±338.27^△△
High dose	283.08±12.89^△△	8 180.33±463.37^△△

Group	Unilateral kidney weight（m/g）	Kidney coefficient（η/%）
Control	1.17±0.23	0.38±0.04
Model	1.69±0.21	0.58±0.09^*
BZM	1.42±0.46	0.43±0.03^△
TFCS
Low dose	1.58±0.08	0.55±0.05
Medium dose	1.35±0.26	0.49±0.09^△
High dose	1.28±0.09	0.42±0.02^△

Group	CVF
Control	6.63±0.99
Model	53.61±2.76^*
BZM	42.78±2.77^△
TFCS
Low dose	38.55±2.19^△
Medium dose	24.59±5.00^△
High dose	19.43±3.12^△

Group	UA [c_B/（μmol·L^-1)]	Cr [c_B/（μmol·L^-1)]	BUN [c_B/（mmol·L^-1)]	IL-6 [ρ_B/（ng·L^-1)]	TNF-α [ρ_B/（ng·L^-1)]
Control	38.57±3.29	50.52±4.72	19.84±2.18	24.37±3.36	40.15±8.22
Model	98.52±11.74^*	84.36±12.37^*	42.15±10.59^*	66.42±12.83^*	102.58±18.62^*
BZM	62.47±8.56^△△	47.22±9.59^△	24.46±7.04^△△	38.41±5.45^△△	74.27±13.61^△△
TFCS
Low dose	75.49±10.92^△	79.54±12.29	39.58±11.52	38.73±8.17^△△	74.59±13.14^△△
Medium dose	58.71±8.28^△△	52.54±9.03^△△	27.51±7.28^△△	32.86±8.29^△△	74.88±13.46^△△
High dose	43.18±6.33^△△	40.65±9.73^△△	18.05±6.27^△△	26.75±6.19^△△	70.45±11.83^△△

Group	β₂-MG	ALB
Control	5.08±0.71	5.50±4.79
Model	39.44±10.14^*	17.81±2.81^*
BZM	26.08±5.42^△△	8.54±2.75^△△
TFCS
Low dose	32.72±8.32^△	10.04±5.04^△
Medium dose	27.64±6.13^△△	11.21±1.10^△△
High dose	22.82±6.67^△△	8.73±3.71^△△

Ameliorative effect of total flavonoids from corn silk on urate nephropathy in rats and its mechanism

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 11

References 31

Related Articles 12

Metrics

Comments

Recommended 10

Group	URAT1	GLUT9	ABCG2
Control	1.027±0.049	1.048±0.061	1.021±0.031
Model	1.415±0.086^*	1.769±0.074^*	0.532±0.020^*
BZM	0.862±0.032^△△	0.507±0.036^△△	0.776±0.023^△△
TFCS
Low dose	0.488±0.149^△△	1.383±0.084^△	0.649±0.041^△△
Medium dose	0.857±0.037^△△	0.804±0.052^△△	0.691±0.026^△△
High dose	0.814±0.011^△△	0.842±0.047^△△	0.741±0.038^△△

[1]	Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69.
[2]	Meng QU,Rui HUANG,Xinda JU,Yuxin LIU,Jichen XIA,Jiaxin HUANG,Chunyan YU,Zhiheng DONG. Ameliorative effect of ginsenoside Rh1 on kidney injury in diabetic mice through activation of Nrf2/HO-1 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1565-1571.
[3]	Fangyang JIANG,Jing XIAO,He CHANG,Mingyang SUN,Wenjing ZHANG,Guangfu LYU,He LIN,Zhe LIN,Xiaowei HUANG,Yuchen WANG. Effect of polygonatum odoratum polysaccharide on acute kidney injury in mice induced by cisplatin and its ferroptosis mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1235-1242.
[4]	Li LIU,Linsheng HUANG,Yongheng ZHAO,Wenjie CAO,Yongshuai QIAN,Huifan YU,Fei LI. Network pharmacological analysis on Balanophora involucrataHook.f. in treatment of hyperuricemia and its therapeutic effect on hyperuricemia cell model and hyperuricemia model mouse [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 58-70.
[5]	Meng QYU,Yuzhu JIANG,Rui HUANG,Zhenzhuo MA,Jichen XIA,Yuan ZHANG,Zhiheng DONG. Protective effect of ginsenoside Rh2 on kidney injury in rats with diabetic kidney lesions and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1168-1173.
[6]	Qiaoling YANG,Lu FU,Yu SHI,Yanjue YE,Rifeng LU,Yong LIU,Li YIN. Inhibitory effect of rosiglitazone on ferroptosis of renal tubular epithelial cells in mice with acute renal injury induced by lipopolysaccharide and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 351-359.
[7]	Xin LI,Xu DING,Xiaomeng LIU,Xinchan LIU,Zhou WU,Weixian YU. Effect of silencing information regulator 1 on kidney injury in chronic periodontitis model rats [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1200-1208.
[8]	Liyan ZHU,Yaoming WANG,Zheng QIN,Huanhuan ZHAO,Zengying WANG,Xiuhong YANG. Improvement effect of angiotensin(1-7) on kidney injury induced by limb ischemia-reperfusion in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 834-841.
[9]	ZHANG Li, CUI Xiaoqian, SHANG Yunlong, CHENG Yuanjuan, SONG Debiao. Multiple organ dysfunction syndrome caused by diabetic ketoacidosis combined with hyperglycemic hyperosmolar state:A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2020, 46(05): 1070-1073.
[10]	WANG Jianjun, LIU Yanan, WANG Jianhui, LIU Yan, LI Ying, WANG Ruixue, YANG Xiuhong. Protective effect of diminazene on kidney injury of limb ischemia-reperfusion model mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 14-19.
[11]	WANG Jianxing, JIANG Yan, WANG Yan, WU Lei, MU Yu, HAN Shuying. Influence of extract from fermented buckwheat flower and leaf in kidney injury in type 2 diabetic db/db mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 95-100.
[12]	. Up-regulation effect of cyclosporine A on level of kidney injury molecule-1 in culture supernatant of human kidney cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2014, 40(06): 1201-1205.